10x Genomics Inc (TXG)
37.84
+0.94
(+2.55%)
USD |
NASDAQ |
Mar 28, 14:19
10x Genomics Revenue (TTM): 618.73M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 618.73M |
September 30, 2023 | 590.98M |
June 30, 2023 | 568.41M |
March 31, 2023 | 536.20M |
December 31, 2022 | 516.41M |
September 30, 2022 | 503.71M |
June 30, 2022 | 497.93M |
March 31, 2022 | 499.16M |
December 31, 2021 | 490.49M |
September 30, 2021 | 459.18M |
Date | Value |
---|---|
June 30, 2021 | 405.70M |
March 31, 2021 | 332.76M |
December 31, 2020 | 298.84M |
September 30, 2020 | 261.92M |
June 30, 2020 | 251.31M |
March 31, 2020 | 264.22M |
December 31, 2019 | 245.89M |
September 30, 2019 | 221.16M |
June 30, 2019 | 196.56M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
196.56M
Minimum
Jun 2019
618.73M
Maximum
Dec 2023
408.40M
Average
459.18M
Median
Sep 2021
Revenue (TTM) Benchmarks
American Shared Hospital Services | 20.66M |
Novo Integrated Sciences Inc | 13.04M |
Astrana Health Inc | 1.387B |
Cryo-Cell International Inc | 31.34M |
P3 Health Partners Inc | 1.178B |